A Randomized, Double-Blinded, Placebo-controlled, Dose-Escalation, Age-Descending Study to Assess the Safety and Tolerability of Live Attenuated, Oral Shigella WRSS1 Vaccine in Bangladeshi Adults and Children
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Shigella sonnei vaccine (Primary)
- Indications Shigella infections
- Focus Adverse reactions
- 08 Feb 2019 Biomarkers information updated
- 20 Oct 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 27 Aug 2013 Planned end date changed from 1 Feb 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.